Christopher Stone
2011
In 2011, Christopher Stone earned a total compensation of $654.5K as Vice President, General Counsel and Secretary at PDL BioPharma, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $173,438 |
|---|---|
| Salary | $360,635 |
| Stock Awards | $110,600 |
| Other | $9,800 |
| Total | $654,473 |
Stone received $360.6K in salary, accounting for 55% of the total pay in 2011.
Stone also received $173.4K in non-equity incentive plan, $110.6K in stock awards and $9.8K in other compensation.
Rankings
In 2011, Christopher Stone's compensation ranked 7,195th out of 10,747 executives tracked by ExecPay. In other words, Stone earned more than 33.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,195 out of 10,747 | 33rd |
Division Manufacturing | 2,627 out of 3,960 | 34th |
Major group Chemicals And Allied Products | 633 out of 1,033 | 39th |
Industry group Drugs | 436 out of 781 | 44th |
Industry Biological Products, Except Diagnostic Substances | 71 out of 157 | 55th |
Source: SEC filing on April 17, 2014.
Stone's colleagues
We found five more compensation records of executives who worked with Christopher Stone at PDL BioPharma in 2011.
2011
Christine Larson
PDL BioPharma
Chief Financial Officer
2011
John McLaughlin
PDL BioPharma
Chief Executive Officer
2011
Caroline Krumel
PDL BioPharma
Former Vice President of Finance and Principal Accounting Officer
2011
Danny Hart
PDL BioPharma
General Counsel
2011
Karen Wilson
PDL BioPharma